DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» CDKN2A
CDKN2A
The P16 (Cdkn2a/Ink4a) Tumor-Suppressor Gene in Head
Infrequent Methylation of CDKN2A(Mts1p16) and Rare Mutation of Both CDKN2A and CDKN2B(Mts2ip15) in Primary Astrocytic Tumours
Increased Expression of Unmethylated CDKN2D by 5-Aza-2'-Deoxycytidine in Human Lung Cancer Cells
Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant
Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs Jennifer L
DNA Methylation and the Mechanisms of CDKN2A Inactivation in Transitional Cell Carcinoma of the Urinary Bladder Andrea R
Cdkn2a, the Cyclin-Dependent Kinase Inhibitor Encoding P16ink4a and P19arf, Is a Candidate for the Plasmacytoma Susceptibility Locus, Pctr1
CDKN2A Mutation and Deletion Status in Thin and Thick Primary Melanoma1
Aberrations of the P53 Pathway Components P53, MDM2 And
The Role of Fos and Junb in the Reprogramming of Acute Myeloid Leukemia Cells
HKR3 Regulates Cell Cycle Through the Inhibition of Htert In
A Common Variant of CDKN2A (P16) Predisposes to Breast Cancer
Analysis of the CDKN2A, CDKN2B and CDK4 Genes in 48 Australian Melanoma Kindreds
Full Text (PDF)
RB1 and CDKN2A Functional Defects Resulting in Retinoblastoma O
CDKN2A Gene Cyclin Dependent Kinase Inhibitor 2A
CDKN2A (P14arf, P16ink4a), and MTAP Genes in Head and Neck Squamous Cell Carcinoma
A Novel Cdkn2ain-Frame Deletion Associated with Pancreatic Cancer
Top View
Loss-Of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans
Resistance Mechanisms to TP53-MDM2 Inhibition Identified by in Vivo Piggybac Transposon Mutagenesis − − Screen in an Arf / Mouse Model
Identification of Oncogenes Collaborating with P27 Loss By
The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
Cdkn2a/P16 Regulates Fasting-Induced Hepatic
Expression Profiles and Clinical Relationships of ID2, CDKN1B, And
High Positive Correlations Between ANRIL and P16-CDKN2A/P15
Epigenetic Alterations Upstream and Downstream of P53 Signaling in Colorectal Carcinoma
CDKN2A) Locus in Adipose Tissue: Implications for Obesity and Type 2 Diabetes
Histone Chaperone Jun Dimerization Protein 2 (Jdp2): Role in Cellular Senescence and Aging
Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment
Affects the Anti‑Tumor Effect of CDK Inhibitor in Somatotroph Adenomas
The Molecular Balancing Act of P16 in Cancer and Aging
Genetic Alterations in Signaling Pathways in Melanoma Frank G
Review Article
Point Mutations Can Inactivate in Vitro and in Vivo Activities of P16ink4a/CDKN2A in Human Glioma
CDKN2A/P16 Is Inactivated in Most Melanoma Cell Lines'
Malignant Pleural Mesothelioma Interactome with 364 Novel Protein-Protein Interactions
Downloaded from Bioscientifica.Com at 09/29/2021 12:42:16PM Via Free Access
CDKN2A Clinical Guide
P14arf Homozygous Deletion Or MDM2 Overexpression in Burkitt Lymphoma Lines Carrying Wild Type P53
CDKN2A/P16 and Familial Cancer
Palbociclib in Patients with Pancreatic and Biliary Cancer with CDKN2A
P16 Controls P53 Protein Expression Through Mir-Dependent Destabilization of MDM2 Huda H
Loss of P53 Function at Late Stages of Tumorigenesis Confers ARF-Dependent Vulnerability to P53 Reactivation Therapy
Pathogenic CDKN2A Variants and Pancreatic Cancer SUPPLEMENTARY
The Yin and Yang-Like Clinical Implications of the CDKN2A/ARF/CDKN2B Gene Cluster in Acute Lymphoblastic Leukemia
Detection of Numerical Abnormalities of Chromosome 9 and P16/CDKN2A Gene Alterations in Ovarian Cancer with Fish Analysis
The Role of MITF in the Regulation of CDKN2A in Melanoma
Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs
Pattern of Retinoblastoma Pathway Inactivation Dictates Response to CDK4/6 Inhibition in GBM
Download Article (PDF)